RECURSION PHARMACEUTICALS, INC. - RXRX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$1.363B

QoQ value delta ($000)

+$307.5M (+29.14%)

Implied price effect (QoQ)

+19.5%

Total shares

371,452,046

QoQ shares delta

+27,723,685 (+8.07%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 349 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	184,618	50,304,691	0.0%
ARK Investment Management LLC	151,709	41,337,632	0.98%
STATE STREET CORP	127,371	34,706,130	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	114,252	31,131,599	0.01%
BAILLIE GIFFORD & CO	86,200	23,487,907	0.08%
VANGUARD CAPITAL MANAGEMENT LLC	83,551	22,765,940	0.0%
GEODE CAPITAL MANAGEMENT, LLC	50,724	13,819,135	0.0%
SOFTBANK GROUP CORP.	50,046	13,636,515	0.28%
MIC Capital Management UK LLP	35,393	9,644,033	8.98%
UBS Group AG	32,835	8,947,102	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	29,517	8,042,928	0.0%
NORGES BANK	25,079	6,833,534	0.0%
Data Collective IV GP, LLC	21,803	5,941,120	27.76%
Sumitomo Mitsui Trust Group, Inc.	20,227	5,511,687	0.01%
Amova Asset Management Americas, Inc.	20,227	5,511,687	0.26%
NORTHERN TRUST CORP	17,462	4,758,236	0.0%
MARSHALL WACE, LLP	17,302	4,714,577	0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	15,187	4,138,286	0.0%
DCVC Opportunity Fund II GP, LLC	14,500	3,951,141	84.3%
GOLDMAN SACHS GROUP INC	14,378	3,917,858	0.0%
VANGUARD FIDUCIARY TRUST CO	12,736	3,470,558	0.0%
TWO SIGMA INVESTMENTS, LP	12,307	3,353,658	0.01%
FIRST TRUST ADVISORS LP	11,163	3,041,829	0.01%
MORGAN STANLEY	10,068	2,743,499	0.0%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd	9,557	2,604,317	0.61%